Gene Expression Atlas home | about the project | faq | feedback | blog | das | api | help
CLTC
REST API REST API
Homo sapiens
CLTC is differentially expressed in 244 experiments: 85 organism parts: skeletal muscle, heart, ... (83 more);, 197 disease states: normal, acute myeloid leukemia, ... (195 more);, 76 cell types 329 cell lines 31 compound treatments and 69 other conditions.
Synonyms Hc, CLTCL2
Orthologs ENSCING00000009806 (Ciona intestinalis)   cltcb (Danio rerio)   CLTC (Bos taurus)   CHC1 (Saccharomyces cerevisiae)   ENSCING00000001739 (Ciona intestinalis)   Cltc (Rattus norvegicus)   CLTC (Gallus gallus)   cltca (Danio rerio)   Cltc (Mus musculus)   Chc (Drosophila melanogaster)   cltc (Xenopus laevis)   CLTC (Canis familiaris)   (Compare orthologs)
Gene Ontology Term cytosol, plasma membrane, clathrin coat of trans-Golgi network vesicle, negative regulation of epidermal growth factor receptor signaling pathway, clathrin coat of coated pit, clathrin coat, protein binding, cellular membrane organization, epidermal growth factor receptor signaling pathway, clathrin-coated vesicle, intracellular protein transport, structural molecule activity, receptor-mediated endocytosis, receptor internalization, post-Golgi vesicle-mediated transport, vesicle-mediated transport, axon guidance, spindle, mitosis, membrane coat, cytoplasmic vesicle, cytoplasmic vesicle membrane, mitochondrion, transferrin transport, nerve growth factor receptor signaling pathway, melanosome
InterPro Term Clathrin_H-chain_propeller_rpt, Clathrin_H-chain/VPS_repeat, Clathrin_heavy_chain, Clathrin_H-chain_linker_core
UniProt Accession Q00610, Q49AL0
Search EB-eye ENSG00000141367
Show more properties
Experimental Factors
Organism part

studied in E-GEOD-803, E-GEOD-15765, E-AFMX-5, E-MEXP-1251, E-MTAB-24, ... (23 experiments)

3
1
Number of published studies where the gene is over/under expressed compared to the gene's overall mean expression level in the study.

anatomogram

Cell line

studied in E-GEOD-5258, E-GEOD-4525, E-GEOD-19639, E-GEOD-18005, E-GEOD-4717, ... (29 experiments)

Factor Value U/D Experiments
BT474
3
E-MTAB-37, E-MEXP-440, E-MTAB-62
CCRFCEM
2
E-MTAB-37, E-GEOD-24147
HL-60
2
E-GEOD-5258, E-GEOD-24147
MCF-7
2
E-GEOD-20081, E-GEOD-3529
MDA468
2
E-MEXP-440, E-MTAB-62
MOLT4
2
E-MTAB-62, E-MTAB-37
323 more value(s).


Cell type

studied in E-TABM-40, E-GEOD-22373, E-GEOD-21668, E-GEOD-3920, E-MEXP-750, ... (42 experiments)

Factor Value U/D Experiments
CD8+ T cell
2
E-AFMX-5, E-MTAB-25
endothelial cell
2
E-GEOD-19240, E-GEOD-3920
LCC
1
E-GEOD-19188
n/a
1
E-MTAB-24
CD34+CD38-/lowCD19+ cell
1
E-MEXP-1403
CD34+
1
E-AFMX-5
70 more value(s).


Disease state

studied in E-GEOD-3307, E-GEOD-2466, E-MEXP-2280, E-MTAB-62, E-GEOD-2113, ... (52 experiments)

Factor Value U/D Experiments
lung adenocarcinoma
4
E-MTAB-62, E-MEXP-231, E-MTAB-37, E-GEOD-2514
glioblastoma
3
E-MTAB-62, E-GEOD-6014, E-MTAB-37
gastric carcinoma
2
E-GEOD-15460, E-GEOD-2685
control
2
E-GEOD-21912, E-GEOD-20295
prostate carcinoma
2
E-MEXP-2034, E-MTAB-62
no tendon xanthomas
1
E-MTAB-62
191 more value(s).


Compound treatment

studied in E-GEOD-6907, E-GEOD-5741, E-GEOD-3720, E-GEOD-5824, E-TABM-868, ... (22 experiments)

Factor Value U/D Experiments
glutamine
2
E-MEXP-1335, E-MEXP-941
lipopolysaccharide
2
E-MEXP-1958, E-TABM-868
Cxcl12
1
E-GEOD-7307
vanadium pentoxide
1
E-GEOD-5339
NaOH
1
E-MEXP-2590
unknown
1
E-GEOD-7307
25 more value(s).


Age years

studied in E-TABM-783

Factor Value U/D Experiments
1
E-TABM-783
n/a
1
E-TABM-783


Agent
studied in E-GEOD-19519

BioSourceProvider
studied in E-GEOD-19519, E-GEOD-19480

Blood/non-blood meta-groups
studied in E-MTAB-62

Bmngrd
studied in E-GEOD-20194, E-GEOD-16716

Cell treatment
studied in E-MEXP-1192

Chromosomal aberration
studied in E-TABM-125

Clinical history
studied in E-GEOD-19743, E-GEOD-7967, E-TABM-125, E-GEOD-21589, E-GEOD-16363, ... (7 experiments)

Clinical info
studied in E-GEOD-19743, E-MTAB-37, E-GEOD-19348, E-GEOD-860, E-MEXP-1251, ... (11 experiments)

Clinical treatment
studied in E-GEOD-1743, E-GEOD-6532

coriell cell line repository identifier
studied in E-GEOD-19519

Developmental stage
studied in E-GEOD-3140, E-MEXP-2359, E-GEOD-6236, E-MTAB-62

dfs time (months)
studied in E-GEOD-21653

Disease staging
studied in E-GEOD-19743, E-MEXP-2280, E-GEOD-21138

Environmental stress
studied in E-GEOD-1643, E-GEOD-3720

Er
studied in E-GEOD-20194, E-GEOD-16716

Estrogen receptor status
studied in E-GEOD-6532, E-GEOD-20194, E-GEOD-16716

Ethnic group
studied in E-GEOD-20194, E-GEOD-16716

Ethnicity
studied in E-GEOD-16363

family id
studied in E-GEOD-19519

Genetic modification
studied in E-GEOD-8023, E-MEXP-1482, E-GEOD-7578, E-GEOD-17385, E-GEOD-20847, ... (7 experiments)

Genotype
studied in E-GEOD-2466, E-GEOD-17476, E-GEOD-22593, E-TABM-321, E-TABM-601, ... (7 experiments)

369 groups
studied in E-MTAB-62

4 groups from blood to incompletely diff
studied in E-MTAB-62

96 groups
studied in E-MTAB-62

Growth condition
studied in E-TABM-263, E-MEXP-1220, E-GEOD-5681, E-GEOD-7011, E-GEOD-20540, ... (9 experiments)

Her2 fish
studied in E-GEOD-20194, E-GEOD-16716

Her2 ihc
studied in E-GEOD-20194, E-GEOD-16716

Her2 status
studied in E-GEOD-20194, E-GEOD-16716

Histology
studied in E-TABM-234, E-TABM-276, E-GEOD-20194, E-GEOD-16716

Individual
studied in E-TABM-325, E-MTAB-197, E-GEOD-1926, E-MEXP-2069, E-TABM-15, ... (32 experiments)

Infection
studied in E-MEXP-1274, E-GEOD-12254, E-GEOD-980

Injury
studied in E-GEOD-19743

Localisation of metastases
studied in E-GEOD-22541

Material type
studied in E-MEXP-455

Media
studied in E-MEXP-765

15 meta groups
studied in E-MTAB-62

4 meta groups
studied in E-MTAB-62

6 meta groups
studied in E-MTAB-62

Metastasis
studied in E-GEOD-18105

Molecular subtype
studied in E-GEOD-21653

Nbefore
studied in E-GEOD-20194, E-GEOD-16716

Observation
studied in E-TABM-276

organ
studied in E-GEOD-24283

Organism
studied in E-AFMX-1, E-TABM-84

Organism status
studied in E-GEOD-19188

Phenotype
studied in E-GEOD-26495, E-GEOD-1460, E-MEXP-1403

Population
studied in E-GEOD-4922

Progesterone receptor status
studied in E-GEOD-6532

Protocol type
studied in E-GEOD-3254, E-GEOD-19246, E-GEOD-1343

RNAi
studied in E-MEXP-1422, E-MEXP-1509, E-MEXP-101, E-GEOD-3697, E-MEXP-1857 ... (5 experiments)

Sample preparation
studied in E-GEOD-16728, E-GEOD-12710

Sample type
studied in E-TABM-783

sampleID
studied in E-GEOD-24283

Sampling time point
studied in E-GEOD-19743, E-GEOD-21374

Sex
studied in E-GEOD-1643, E-GEOD-2466, E-GEOD-7307

Stimulation
studied in E-GEOD-20114, E-GEOD-11428

stimulus
studied in E-GEOD-22103

Subtype
studied in E-GEOD-24283

Survival time
studied in E-GEOD-19188

Tbefore
studied in E-GEOD-20194, E-GEOD-16716

Test result
studied in E-TABM-276

Tissue
studied in E-GEOD-30573

Transfection
studied in E-GEOD-14680

Treatment
studied in E-GEOD-16837, E-MEXP-973, E-GEOD-19246, E-GEOD-13818

Treatment code
studied in E-GEOD-20194, E-GEOD-16716

Treatments comments
studied in E-GEOD-20194, E-GEOD-16716

Tumor grading
studied in E-GEOD-1561, E-GEOD-6532, E-GEOD-4922

Vehicle
studied in E-GEOD-5258

Processing time: 0.395 secs.
 
Gene Expression Atlas 2.0.11.1- 12/23/11 3:09:34 PM